About the Company

Epione Biopharmaceuticals was founded in 2015 to provide the benefits of highly efficacious, injectable medications for the treatment of pain in multiple markets without the burden and risks that opiate-based therapies offer.

The Epione Product Pipeline

Epione has several products under development in the pain (EP), oncology (EC), ocular (EE), and orthopedic (EB) market spaces.

Technical Partners

   OMPI Pharma

Schott Glass






Avomeen Analytical Services



Owen Mumford, Ltd.


AES Clean Technology




Silicon Valley Bank



Safe, non-addictive pain relief